X
MRK icon

Xponance’s Merck MRK Stock Holding History

Xponance’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$56.9M Buy
473,091
+59,880
+14% +$6.91M 0.4% 36
2025
Q4 		$43.5M Buy
413,211
+2,066
+0.5% +$194K 0.33% 41
2025
Q3 		$34.5M Sell
411,145
-19,686
-5% -$1.62M 0.27% 50
2025
Q2 		$34.1M Sell
430,831
-195,665
-31% -$15.6M 0.29% 47
2025
Q1 		$56.2M Buy
626,496
+22,900
+4% +$2.14M 0.54% 25
2024
Q4 		$60M Buy
603,596
+18,457
+3% +$1.9M 0.55% 25
2024
Q3 		$66.4M Sell
585,139
-6,255
-1% -$743K 0.64% 21
2024
Q2 		$73.2M Buy
591,394
+189,196
+47% +$24.4M 0.75% 17
2024
Q1 		$53.1M Sell
402,198
-10,358
-3% -$1.28M 0.56% 26
2023
Q4 		$45M Buy
412,556
+28,406
+7% +$2.95M 0.54% 28
2023
Q3 		$39.5M Buy
384,150
+5,962
+2% +$643K 0.54% 27
2023
Q2 		$43.6M Sell
378,188
-58,598
-13% -$6.65M 0.58% 26
2023
Q1 		$46.5M Buy
436,786
+12,970
+3% +$1.4M 0.68% 24
2022
Q4 		$47M Buy
423,816
+41,361
+11% +$4.23M 0.76% 22
2022
Q3 		$32.9M Buy
382,455
+41,273
+12% +$3.68M 0.63% 25
2022
Q2 		$31.1M Buy
341,182
+137,166
+67% +$12.2M 0.62% 25
2022
Q1 		$16.7M Buy
204,016
+4,706
+2% +$371K 0.28% 68
2021
Q4 		$15.3M Buy
199,310
+68,210
+52% +$5.43M 0.24% 76
2021
Q3 		$9.85M Sell
131,100
-23,410
-15% -$1.78M 0.19% 94
2021
Q2 		$12M Sell
154,510
-326,838
-68% -$24.3M 0.22% 80
2021
Q1 		$35.4M Sell
481,348
-1,811
-0.4% -$134K 0.75% 18
2020
Q4 		$37.7M Buy
483,159
+2,991
+0.6% +$229K 0.82% 18
2020
Q3 		$38M Sell
480,168
-28,304
-6% -$2.22M 0.93% 16
2020
Q2 		$37.5M Buy
+508,472
New +$38.3M 0.97% 13

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Xponance's MRK Position: Q1 2026 in Review

Xponance increased its Merck (MRK) stake by 14% in Q1 2026, buying an estimated $6.91M and bringing the position to 473,091 shares worth $56.9M. The position accounts for 0.4% of the portfolio, ranked #36.

Xponance first reported a position in MRK in Q2 2020 and has held it in 24 quarters since. The position peaked at $73.2M in Q2 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Xponance held 473,091 shares of Merck worth $56.9M as of Q1 2026.
  • Xponance bought 59,880 Merck shares in Q1 2026, an estimated $6.91M.
  • Merck made up 0.4% of Xponance's portfolio in Q1 2026, its #36 holding.
  • Xponance first reported a position in Merck in Q2 2020 and has held it in 24 quarters since.
  • Xponance's Merck position peaked at $73.2M in Q2 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.